Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omya
Oftringen, Aargau, Switzerlandomya.com ↗
- Ownership
- Private
- Employees
- ~8500
- Development stage
- Commercial
01
Overview
Omya supplies high-purity natural minerals such as calcium carbonate for use as pharmaceutical excipients and APIs. Their Omyapharm technology enables the production of orally dispersible tablets with rapid disintegration. They were the first to achieve CEP/CoS certification for natural calcium carbonate as an API under European Pharmacopoeia standards. No clinical results apply since they do not develop therapeutics themselves.
- Therapeutic areas
- Other
- Modalities
- Excipient (e.g., calcium carbonate-based excipients)Active pharmaceutical ingredient (natural calcium carbonate)
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Omya.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omya.